Rosuvastatin 20mg + Clopidogrel 75mg + Aspirin 75mg is a comprehensive cardiovascular combination therapy formulated to manage dyslipidemia and prevent thrombotic events. Rosuvastatin, a potent statin, reduces LDL cholesterol and triglycerides while increasing HDL cholesterol, helping prevent plaque formation in arteries. Clopidogrel and Aspirin are antiplatelet agents that prevent blood clot formation by inhibiting platelet aggregation. This triple-action formulation is widely used in patients with coronary artery disease, post-angioplasty, post-stent placement, and those at high risk of heart attack and stroke. It provides effective lipid control and dual antiplatelet protection, improving long-term cardiovascular outcomes.